A novel pharmacological inhibitor of MAP4K4 activity attenuates metabolic dysfunction-associated steatohepatitis. F Ampadu, N Patil, V Eeda, I Rus, W Jung, A Ali… Elsevier. 2026-02-05.
A novel pharmacological inhibitor of MAP4K4 activity attenuates metabolic dysfunction-associated steatohepatitis
F Ampadu, N Patil, V Eeda, I Rus, W Jung, A Ali…
Elsevier
2026-02-05
